Skip to search.
 FTSE 100 Down 0.67%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
8.58 Down 0.07(0.81%) 2 Jul 21:00
Add to Portfolio
Prev Close:8.65
Open:8.64
Bid:8.24 x 600
Ask:8.66 x 200
1y Target Est:15.81
Beta:1.62
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:8.48 - 8.73
52wk Range:6.61 - 16.87
Volume:1,601,294
Avg Vol (3m):3,270,180
Market Cap:1.01b
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNDown 0.81%1.01b
GSKUp 0.28%102.06b
JNJDown 0.03%272.98b
RHHBYUp 0.09%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.73
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-0.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback